Inhibition of SARS-CoV-2 Replication in the Lung with siRNA/VIPER Polyplexes

0
272
Researchers developed a formulation for pulmonary administration of siRNA to suppress SARS-CoV-2 replication in lung epithelial cells.
[Journal of Controlled Release]
Full ArticlePress ReleaseGraphical Abstract